Nine Diagnostics participated in the BioTools Innovator pitch event, a competitive platform spotlighting emerging companies building enabling technologies for life sciences and diagnostics. BioTools Innovator is recognized for elevating high-impact tool and platform companies that can accelerate research workflows and downstream clinical translation. During the event, we presented our nanosensor-enabled, machine learning-driven approach to capturing complex molecular fingerprints from small-volume samples, and how this foundation can support biomarker-agnostic diagnostics across challenging disease areas. Participation helped increase visibility with a targeted audience of investors, strategic partners, and ecosystem leaders focused on next-generation research and diagnostic platforms, and it supported new conversations around partnerships and commercialization pathways.
